About Growth Hormone
Full Hormone Modulation for Men and Women
Our hormone system is best understood if you think of it as a cascade with the brain at the top followed by the pituitary gland, then target organs (i.e., ovaries, thyroid, testicles), and finally physical and mental functions (i.e., skin thickness, menstrual periods, sex characteristics, aggression, hair distribution, etc.).
The hypothalamus is part of the brain and is where hormone release originates, starting off the cascade by secreting "releasing hormones" which turn on the pituitary.
The pituitary is known as our "master gland." It sits at the base of our brain and communicates directly with the hypothalamus by special nerves and blood vessels. Releasing hormones travel from the hypothalamus to the pituitary and stimulate the formation and release of pituitary hormones into our circulatory system. The pituitary hormones exert their effects on many of our organs, such as the thyroid, adrenal glands, testicles, ovaries, and breasts.
There are five basic pituitary hormones in which we are interested. They are as follows:
The pituitary hormones are released into the general circulation and have effects on specific target organs, which, in turn, release hormones of their own. Thus, the pituitary hormones act like air traffic controllers-they survey the scene, determine what is needed, and then tell the organs in the body when to release their hormones. In the past, if a pituitary gland was removed or destroyed due to a tumor in an adult Growth Hormone was not replaced, even though the more "essential" hormones, such as thyroid, hydrocortisone, and testosterone or estrogen/progesterone were replaced. It wasn't until the work of Dr. B. Bengtsson and Dr. Daniel Rudman that the value of Growth Hormone in adults was recognized. It was found that GH deficient patients had almost 50% higher rate of death from heart disease than expected. Dr. Bengtsson replaced Growth Hormone in pituitary deficient patients and achieved excellent results. In a 1990 New England Journal of Medicine article, Dr. Rudman reported on his pioneering experiments with the use of human Growth Hormone (hGH) in elderly veterans. He discovered that their body fat decreased and lean muscle mass, strength, skin thickness, and bone density increased. In other words, he was able to slow down the usual progression of aging by bringing patient's blood IGF levels up to those equivalent to a younger age group. In 1999, the National Institute on Aging completed another landmark study that was designed to either refute or substantiate the results of Dr. Rudman and also to extend his study by measuring other parameters. This was a double-blind, placebo-controlled, multi-center trial in both men and women with a large number of patients. This study involved not only Growth Hormone but gonadal (sex) steroids. This study not only confirmed the benefits of Growth Hormone that Dr. Rudman had asserted, but also demonstrated that the addition of gonadal steroids improved the effectiveness of Growth Hormone for both men and women. Although the NIA study showed that Growth Hormone alone did not increase muscle strength, it did substantially increase lean muscle and aerobic capacity. The addition of testosterone to Growth Hormone did, however, increase muscle strength substantially.
Growth Hormone has many metabolic effects, the most predominant of which is protein synthesis. Growth Hormone is released in bursts, most of which occur during certain stages of sleep. After we stop growing and become adults, there is a significant decrease in the amount of Growth Hormone we produce. IGF is a by-product of Growth Hormone, and is thought to be responsible for most of the anabolic (building) effects of the hormone itself. Fortunately, IGF levels are fairly constant in the blood and can be measured more easily than Growth Hormone. We, therefore, measure blood levels of IGF to assess the amount of circulating Growth Hormone in the body.
Growth Hormone is essential for bone and organ growth in our youth. Too little causes dwarfism; too much causes gigantism. It is very clear that GH and IGF start to decrease sometime after age 15-20 and continue to do so quite rapidly. Although GH is no longer needed for growth, per se, after reaching adulthood, GH is essential for many other vital functions, and the significantly lowered levels seen as we age are thought to be correlated with everything from diminished energy to weight gain (fat) and decreased muscle mass.
The Safety of Human Growth Hormone
Taking Growth Hormone raises IGF-1 levels in the blood. It is the higher IGF-1 that mediates all the effects attributed to Growth Hormone. Most of the studies about the use of Growth Hormone in adults and children fail to show any risk of cancer related to the use of Growth Hormone or higher levels of IGF-1. In fact, in a review article published in the New England Journal of Medicine on October 14, 1999, authored by Mary Lee Vance, M.D. and Nellie Mauras, M.D., after an exhaustive literature search, concluded that "there is at present no evidence that Growth Hormone modulation effects the risk of cancer." Several other studies show no difference in IGF1 levels between normal healthy men and those with prostate cancer at the time of diagnosis and beyond. We therefore have conflicting data and cannot come to a definite conclusion as to the possible risk of growth hormone in the development of prostate cancer. This would require a 5-10 year prospective double-blind, placebo controlled trial, which has not yet been done. Another recent study points to a higher incidence of breast cancer in pre-menopausal women (but not postmenopausal) who had higher IGF-1 levels one to five years prior to the onset of breast cancer. Studies like this which show an association (two variables present simultaneously) do not demonstrate cause and effect. Tripping on the sidewalk as a red car passes may be 100% independent of the red car (association only), or you may have distracted by the car and missed the elevated slab in front of you (cause and effect). It may be 20 years before we know if there is any cause and effect between higher IGF-1 and risk for breast cancer in premenopausal women. Although the majority of studies overwhelmingly point toward the safety of human Growth Hormone, there is, as in virtually any area of medical science, some conflicting data among studies that confuses the issue. This is true because of the complex nature of the human body and its physiology-and the truism that medicine is not an exact science. As in all aspects of medical therapeutics, each of us must evaluate the information that is available, along with our needs and desires and measure these against the potential risk, if any. Your physician can help you understand and evaluate all the information available with as little prejudice as possible. Obviously we feel that for most patients the benefit of Growth Hormone therapy far outweighs the risk- otherwise we would not be pursuing this type of medical practice. Only you however, can make the decision for yourself.
To put it into context, similar controversy has surrounded the use of estrogen in post-menopausal women for the past 30 years. We now know that estrogen replacement in women may increase the risk of breast and endometrial cancer in some women with family histories of breast cancer, and other risk factors. However, because of estrogen's proven protective effects against many other diseases (Alzheimer's disease, heart disease, osteoporosis and colon cancer), overall mortality is lower in women who take estrogen than in those who do not. It will be many years before we have as much data on Growth Hormone as we do on estrogen; but we feel that for most people who have low IGF-1 levels, the benefits of taking Growth Hormone outweigh the risks.
Those studied and published benefits include:
Anecdotally claimed benefits include:
Whether or not they extend life span won't be determined for many years. What we do know is that the enhancement in the quality of our lives by the use of Growth Hormone is substantial.
Those Who Should Avoid Growth Hormone
As with most other therapies, people with certain specific diagnoses should avoid growth hormone because it could exacerbate their illness. We call these "contraindications" to the use of growth hormone: the presence of a cancer or tumor; uncontrolled diabetes; unusual lung diseases such as pulmonary fibrosis, sarcoidosis, pneumoconiosis, bronchiolitis obliterans, Herman sky-Pudlak Syndrome, or systemic sclerosis. If you've ever been diagnosed with any of these medical problems, please inform your physician.
Thyroid hormone greatly affects our metabolic rate and therefore our body temperature. Without thyroid hormone, we cannot survive. Low thyroid levels cause decreased body temperature, increased cholesterol, and increased body fat. Often undetected in traditional medical practices, low thyroid levels can make it fiendishly difficult to lose weight. They can contribute to a subjective feeling of sluggishness and low energy as well as depression. As we age, our thyroid levels sometimes decrease and our body temperature and metabolism dip below normal. Supplementation of thyroid hormone is easy and inexpensive. The goal is to restore T3 and T4 to their natural ratio and blood concentrations.
These hormones are essential for normal reproductive function and the secondary sexual characteristics. They include testosterone, estrogen, and progesterone.
The adrenal glands release hydrocortisone (cortisol) and other hormones known as adrenal steroids. They are essential for life and are very important in our response to physical and emotional stress. In general, they do not decline with age, as do most of our other hormones. All the adrenal and gonadal steroids are derived from the basic cholesterol molecule. Through several biosynthetic pathways, cholesterol is transformed into different steroid hormone molecules before it becomes estrogen, progesterone or testosterone. Please keep in mind that when we take pregnenolone, DHEA (dehydroepiandrosterone) or androstenedione, we may influence the levels of their end products: testosterone, estrogen and progesterone. Therefore, it is important to monitor levels of both the administered hormone and its end products.
-thanks to Cengenics
News & Promotions
ABOUT BeMedispa | PARTNER LINKS | SERVICES | SITE MAP | CHARITIES |
CMS 2.2 Designed by so2 | Developed by 3DD | Login